Evidence map›Paper›PMID 35315725›Full record

ArticleTechnology in cancer research & treatment

Yangyang Ye, Qian Shi, Ting Yang, Fei Xie, Xiang Zhang, Bin Xu, Jingwen Fang, Jiangning Chen, Yujing Zhang, Jing Li

Abstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Nature Inspired Delivery Vehicles for CRISPR-Based Genome Editing.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  5. Review
  6. Translational cancer research · 2025
    Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Tracking tools of extracellular vesicles for biomedical research.Frontiers in bioengineering and biotechnology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yangyang Ye12581Nanjing University, Nanjing, Jiangsu, China.
Qian Shi12581Nanjing University, Nanjing, Jiangsu, China.
Ting Yang12581Nanjing University, Nanjing, Jiangsu, China.
Fei Xie12581Nanjing University, Nanjing, Jiangsu, China.
Xiang Zhang12581Nanjing University, Nanjing, Jiangsu, China.
Bin Xu12581Nanjing University, Nanjing, Jiangsu, China.
Jingwen Fang12581Nanjing University, Nanjing, Jiangsu, China.
Jiangning Chen12581Nanjing University, Nanjing, Jiangsu, China.
Yujing Zhang12581Nanjing University, Nanjing, Jiangsu, China.
Jing Li12581Nanjing University, Nanjing, Jiangsu, China.ORCID 0000-0002-3000-1974

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Extracellular VesiclesMelanomaCell CommunicationCRISPR-Cas SystemsGene EditingHumansCRISPR-Cas9EV trackingtumor EV distribution

Identifiers

PMID35315725
PMCPMC8943546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.